AMR (Antimicrobial Resistance) kills and debilitates millions of people annually, especially in low- and middle-income countries (LMICs). It also turns back years of progress on the UN Sustainable Development Goals, particularly in global health, food safety and security, economic growth, poverty alleviation, and the environment. Economically, the World Bank estimates AMR will cost economies $100 trillion USD from 2017 – 2050. More must be done urgently and collectively to mitigate AMR, while we still can. Ensuring that life-saving antimicrobials remain available as effective treatment options will require a massive, coordinated global effort. 

The AMR Policy Accelerator at York University’s Global Strategy Lab is a policy think-tank that bridges AMR science and policy and provides policymakers at the national and international levels, with rigorous policy research needed to inform AMR policymaking and National AMR Action Plans. 

This course is designed to help technical professionals (Eg. Medicine, Pharmacy, Veterinary, Epidemiology) make the leap from research and  practice to policy, and to equip them with the tools to make effective policy decisions in the AMR policy space, from a One Health perspective. Taught by leading AMR and health policy experts, this course will provide participants with: 

• A deeper understanding of policy levers and how to use them as AMR leaders in government to make effective decisions. 

• An appreciation of the role of policymaking and governance structures at the national and international levels as they pertain to progress on AMR goals. 

• A stronger foundation in monitoring, evaluating, and learning principles to strengthen AMR policy programs and assess their effectiveness. 

• A robust toolkit and insight into how different types of evidence are developed and used in the policy process, and their relationship(s) to one another